文献速递胸部肿瘤

HO-1敲减通过阻断自噬抑制肺腺癌A549细胞增殖侵袭迁移

[Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

该研究检测了HO-1在肺癌细胞系及人肺腺癌组织中的表达,并通过shRNA敲减A549细胞HO-1,结合自噬诱导剂Torin1或抑制剂Baf A1处理,评估细胞增殖、侵袭和迁移能力。结果显示HO-1在肺癌细胞和肺腺癌组织中高表达,敲减HO-1后自噬标志物LC3B-II/LC3B-I比值和p62升高,细胞增殖、侵袭和迁移均受抑制。结论提示HO-1敲减通过阻止自噬抑制A549细胞恶性行为。

要点

  • HO-1 mRNA在多种肺癌细胞系中显著高于人支气管上皮细胞,人肺腺癌组织中HO-1过表达。
  • 敲减HO-1后LC3B-II/LC3B-I比值和p62蛋白表达均高于对照组(P<0.05),提示自噬受阻。
  • 敲减HO-1可抑制A549细胞增殖、侵袭和迁移,且该效应与自噬状态相关。

核心结论

  • HO-1敲减通过阻止自噬来抑制肺腺癌A549细胞的增殖、侵袭和迁移。

研究设计与样本

  • 基础实验研究:采用RT-qPCR检测HBECs和肺癌细胞系A549、H1299、H358、H1993中HO-1 mRNA表达,免疫组化检测人肺腺癌标本HO-1表达。
  • 通过RNA干扰将HO-1 shRNA转染A549细胞,制备稳定低表达HO-1的细胞(HO-1 shRNA组),并行RT-qPCR和Western blot验证。
  • HO-1 shRNA组和对照组细胞分别用自噬诱导剂Torin1或抑制剂Baf A1处理,Western blot检测LC3B和p62。
  • 采用计数法、Transwell实验和伤口愈合实验分别评估各组A549细胞的增殖、侵袭和迁移能力。

主要发现

  • 肺癌细胞系A549、H1299、H358和H1993中HO-1 mRNA表达均显著高于HBECs,人肺腺癌组织中HO-1过表达。
  • 未处理、Torin1处理和Baf A1处理情况下,HO-1 shRNA组细胞的LC3B-II/LC3B-I比值和p62蛋白表达量均高于相应对照组(均P<0.05)。
  • 经过11 d培养后,HO-1 shRNA组细胞数分别为相应对照组的41.8%、30.4%和14.0%。
  • HO-1 shRNA组下室细胞数分别为(35.7±2.1)、(27.0±1.0)和(38.0±1.0)个/视野,均低于相应对照组[分别为(66.0±9.2)、(39.3±1.2)和(43.0±2.6)个/视野,均P<0.05]。
  • HO-1 shRNA组迁移距离分别为(7.47±0.91)、(4.23±0.82)和(5.42±0.24)mm,均低于相应对照组[分别为(10.07±1.26)、(7.14±0.07)和(12.04±0.80)mm,均P<0.05]。

临床怎么用

  • 该研究为细胞及组织水平的机制探索,提示HO-1/自噬轴可能参与肺腺癌侵袭转移,尚需进一步转化验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects of heme oxygenase-1 (HO-1) knockdown on proliferation, invasion and migration of lung adenocarcinoma A549 cells and explore the mechanism. Methods: The expression levels of HO-1 mRNA in human bronchial epithelial cells (HBECs) and human lung cancer cell lines (A549, H1299, H358 and H1993) were detected by real-time quantitative polymerase chain reaction (RT-qPCR), and immunohistochemistry (IHC) was used to detect the expression level of HO-1 in human lung adenocarcinoma specimens. The HO-1 short hairpin RNA (shRNA) was transfected into A549 cells by RNA interference technique. HO-1 stably deleted A549 cells were selected (HO-1 shRNA group) and verified by RT-qPCR and western blot. HO-1 shRNA A549 cells and control shRNA A549 cells were treated with the inducer of autophagy Torin1 or its inhibitor Bafilomycin A1 (Baf A1), respectively. The expressions of autophagic markers LC3B and p62 were determined by western blot. The proliferation, invasion and migration abilities of each group of A549 cells were assessed by cell counting, Transwell and wound healing assays, respectively. Results: The expressions of HO-1 mRNA in lung cancer cell lines (A549, H1299, H358 and H1993) were significantly higher than that of HBECs, and HO-1 upregulated in human lung adenocarcinoma. The expression of p62 protein and the ratio of LC3B-Ⅱ/ LC3B-Ⅰ in no treatment group, Torin1 treatment group and Baf A1 treatment group were significantly higher than those of the corresponding control group (P<0.05). After 11 days of culture, the number of cells in HO-1 shRNA group were 41.8%, 30.4% and 14.0% of the corresponding control group, respectively. The number of lower chamber cells in HO-1 shRNA group were (35.7±2.1), (27.0±1.0) and (38.0±1.0)/field, respectively, which were lower than (66.0±9.2), (39.3±1.2) and (43.0±2.6)/field of the corresponding control group, respectively (P<0.05). The migration distances of HO-1 shRNA group were (7.47±0.91) mm, (4.23±0.82) mm and (5.42±0.24) mm, which were lower than (10.07±1.26) mm, (7.14±0.07) mm and (12.04±0.80) mm of the corresponding control groups, respectively (P<0.05). Conclusion: Knockdown of HO-1 inhibits the proliferation, invasion and migration of A549 cells by impeding autophagy. 目的: 观察血红素加氧酶1(HO-1)基因敲减对肺腺癌A549细胞增殖、侵袭和迁移的影响,并探讨其机制。 方法: 采用实时荧光定量聚合酶链反应(RT-qPCR)检测人支气管上皮细胞(HBECs)和人肺癌细胞系A549、H1299、H358和H1993中HO-1 mRNA的表达水平,免疫组织化学染色检测人肺腺癌标本组织中HO-1的表达量。采用RNA干扰技术,将HO-1短发卡RNA(shRNA)转染A549细胞,制备稳定低表达HO-1的A549细胞(HO-1 shRNA组),并行RT-qPCR和Western blot验证。应用自噬诱导剂Torin1或抑制剂Bafilomycin A1(Baf A1)处理HO-1 shRNA组A549细胞和对照组细胞,Western blot检测各组自噬标志物LC3B和p62的表达。采用计数法、Transwell实验和伤口愈合实验分别评估各组A549细胞的增殖、侵袭和迁移能力。 结果: 肺癌细胞系A549、H1299、H358和H1993中HO-1 mRNA的表达均显著高于HBECs,人肺腺癌组织中HO-1过表达。未处理、Torin1处理和Baf A1处理情况下,HO-1 shRNA组细胞的LC3B-Ⅱ/LC3B-Ⅰ比值和p62蛋白表达量均高于相应对照组(均P<0.05);经过11 d培养后,HO-1 shRNA组细胞数分别为相应对照组的41.8%、30.4%和14.0%;HO-1 shRNA组下室细胞数分别为(35.7±2.1)、(27.0±1.0)和(38.0±1.0)个/视野,均低于相应对照组[分别为(66.0±9.2)、(39.3±1.2)和(43.0±2.6)个/视野,均P<0.05];HO-1 shRNA组的迁移距离分别为(7.47±0.91)、(4.23±0.82)和(5.42±0.24)mm,均低于相应对照组[分别为(10.07±1.26)、(7.14±0.07)和(12.04±0.80)mm,均P<0.05]。 结论: HO-1敲减通过阻止自噬来抑制肺腺癌细胞增殖、侵袭和迁移。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cao L, Suo XJ, Jiang W, et al. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31770847. doi:10.3760/cma.j.issn.0253-3766.2019.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。